BioNTech has signed a definitive agreement to acquire Biotheus to obtain complete worldwide rights to BNT327/PM8002, a ...

In addition, BioNTech will gain a state-of-the-art biologics manufacturing facility to contribute to its future global manufacturing and supply, and more than 300 Biotheus employees in R&D, ...

BioNTech veröffentlicht Ergebnisse für das dritte Quartal ... Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der ...

namely InstaDeep Ltd (“InstaDeep”), JPT Peptide Technologies GmbH, and BioNTech Innovative Manufacturing Services GmbH. Generally, the Company continues to remain largely dependent on revenues ...

BEIJING (AP) — A closely watched survey on manufacturing in China has edged into positive territory after months of contraction, the government statistics agency said Thursday. The Purchasing ...

Critical Manufacturing wird auf der SEMICON Europa 2024 sein fortschrittliches Manufacturing Execution System präsentieren, das speziell auf die Anforderungen der Halbleiterindustrie ...

In that appearance, the governor blamed former President Donald Trump for losing the most manufacturing jobs in U.S. history. "We know that Donald Trump lost more manufacturing jobs than any ...

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. TheTechOutlook.com takes no editorial responsibility for the same.

BERLIN, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Die Agile Manufacturing GmbH, ein führender Anbieter agiler Fertigungssysteme, gab heute die Verlegung ihres Hauptsitzes von Lupburg, Bayern, nach Berlin ...

BERLIN, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Agile Manufacturing GmbH, a leading innovator in Agile Manufacturing Systems, today announced the relocation of its headquarters from Lupburg, Bavaria ...

Agile Manufacturing GmbH verlegt Hauptsitz nach Berlin - Neues Forschungs- und Entwicklungszentrum geplant 18.10.2024, 19:28 Uhr von dpa-AFX Jetzt kommentieren: 0 Dis­clai­mer: Die hier an­ge ...

In 2021, with the COVID-19 pandemic in full swing, BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) were the darlings of the pharma and biotech worlds. The two mRNA therapy developers created ...